glossary
Website terms
Plain definitions of the terms used across Kode Biotech, from FSL constructs and kodecytes to Kode Immunoeducers and complement.
glossary A–Z
A
- adjuvant
- A component that helps initiate or amplify an immune response to an antigen. Not all vaccines contain added adjuvants. A Kode Immunoeducer has adjuvant-like activity.Related: Kode Immunoeducer · antigen
- AGI-134
- A Gen 2 KIE that presents the α-Gal sugar, developed by Kode Agalimmune for human cancer. It has completed a Phase 1/2a safety and dose-finding study in 38 late-stage human patients, with stable disease in 29% of them.Related: α-Gal · KIE generations
- α-Gal (alpha-Gal)
- An epitope Galα1-3Galβ1-4GlcNAc present within glycoproteins and glycolipids, recognised by anti-Gal antibodies that humans already possess. AGI-134 presents the αGal trisaccharide motif.Related: AGI-134 · pre-existing antibodies
- amphipathic
- Having a water-loving part and a water-hating part. FSL constructs are amphipathic: a water-loving functional head and spacer, and a water-hating lipid tail.Related: FSL construct
- anti-Gal antibodies
- The antibodies against α-Gal that almost everyone already carries, in large amounts. A Kode Immunoeducer that presents α-Gal, such as AGI-134, is designed to recruit them to the tumour.Related: α-Gal · pre-existing antibodies · complement
- antigen
- The material against which an immune response is sought.Related: neoantigen · adjuvant
- antigen-presenting cell
- An immune cell that takes up material, such as tumour fragments, and presents its antigens to T cells.Related: in situ autologous cancer vaccine
- autologous
- From the patient's own body. In an in situ autologous cancer vaccine, the antigens come from the patient's own tumour.Related: in situ autologous cancer vaccine
B
- biosurface engineering
- Changing how a biological surface, such as a cell membrane, interacts with its surroundings by adding molecules to it. FSL constructs are a biosurface engineering tool.Related: Kode Technology
C
- cell surface engineering
- The general term for changing what sits on the outside of a cell. Kode Biotech calls its own approach biosurface engineering, because FSL constructs work on non-biological surfaces as well.Related: biosurface engineering · FSL construct
- cell surface modification
- Adding, removing or altering molecules on a cell's surface. FSL constructs do this by inserting into the membrane, without genetic change and without harming the cell.Related: biosurface engineering · kodecyte
- complement
- One of the most potent components of the innate immune system, contributing to targeted cell destruction, opsonisation, immune-cell recruitment and activation, as well as tissue repair and regeneration. Kode Immunoeducers are designed to activate it.Related: pre-existing antibodies
E
- epitope
- The specific part of a molecule that an antibody recognises and binds to. α-Gal is a sugar epitope.Related: α-Gal · antigen
F
- first-in-human
- The first clinical study in which a candidate is given to people, after laboratory and animal work. K5K is in preparation for its first-in-human study.Related: Phase 1/2a · preclinical
- FSL construct (Function-Spacer-Lipid)
- An amphipathic, self-assembling molecule that attaches almost any small molecule to any surface by non-covalent interaction. Each has a functional head, a spacer and a lipid tail.Related: functional head · spacer · lipid tail
- functional head
- The part of an FSL construct that is presented on the surface: a glycan, peptide, label or other molecule.Related: FSL construct
G
- generations (of KIEs)
- AGI-134 is a Gen 2 KIE. K5K and Kv9 are Gen 3 KIE molecules, identical by structure.Related: AGI-134 · K5K · Kv9
- glycan
- A sugar chain. Many of the shapes that cells, bacteria and viruses use to recognise each other are glycans.Related: glycoconjugate
- GlycoChip
- Glycan arrays from GlycoNZ for profiling which glycans an antibody or lectin binds, with an analysis service for plasma samples.Related: glycan
- glycoconjugate
- A glycan joined to another molecule, such as a lipid. FSL constructs that carry glycans are glycoconjugates.Related: glycan
- glycolipid
- A molecule with a sugar part and a fat (lipid) part. Natural glycolipids on red cells were the starting point for Kode Technology; FSL constructs are their synthetic, water-dispersible equivalent.Related: FSL construct · glycan
- GMP (Good Manufacturing Practice)
- The regulated standard a medicine must be made to before it can be given to people in a clinical trial. A GMP batch is a step every programme must complete.Related: investigational · first-in-human
I
- in situ autologous cancer vaccine
- A vaccine effect intended to happen inside the patient's own tumour (in situ), using the patient's own tumour antigens (autologous), rather than antigens supplied in a vial.Related: Kode Immunoeducer
- intratumoural (intratumoral)
- Given by injection directly into a tumour, rather than into the bloodstream. Kode Immunoeducers are designed to be given this way.Related: in situ autologous cancer vaccine · Kode Immunoeducer
- investigational
- Under research and not approved by any medicines regulator for sale or treatment. Every Kode Immunoeducer programme is investigational.Related: preclinical · first-in-human
K
- K5K
- A novel, fully synthetic construct: an immunotherapeutic developed using Kode Technology's Function–Spacer–Lipid platform: a rhamnose-presenting Gen 3 KIE, developed by KodeRx for human cancer. An investigational candidate; safety and efficacy have not yet been established in humans.Related: rhamnose · Kv9
- Kode Immunoeducer (KIE)
- A membrane-inserting, antibody-recruiting, complement-activating construct with adjuvant-like activity, designed to use the patient's own tumour as the antigen source for in situ vaccination. Spelled out with its acronym: Kode Immuno-Educer (KIE).Related: in situ autologous cancer vaccine · complement
- Kode Technology
- An easy, fast, versatile and controllable technology for modifying almost any cell, virus, organism or surface, built on FSL constructs. First named KODE in 1999.Related: FSL construct
- kodecyte
- “Any living or dead cell which has detectable FSL constructs on its surface.” Almost any cell can be labelled: red and white blood cells, platelets, cell lines, tissue cells and bacteria.Related: kodevirion · serologic mimic
- kodevirion
- A virus modified with FSL constructs, named in the same way as kodecytes. Used in virological research.Related: kodecyte
- Kv9
- A Gen 3 KIE for veterinary cancer, developed by Kode Veterinary Sciences. Identical to K5K by structure. Preliminary canine experience is translational evidence only.Related: K5K
L
- lipid tail
- The part of an FSL construct that anchors it into a membrane or onto a surface.Related: FSL construct
N
- neoantigen
- An antigen created by changes in a patient's tumour and specific to that patient. KIEs use any neoantigens already present in the tumour; they need not be identified in advance.Related: antigen
O
- opsonisation (opsonization)
- Coating a cell or particle with antibody or complement so that immune cells recognise and take it up. It is one of the steps a Kode Immunoeducer is designed to trigger at the tumour.Related: complement · antigen-presenting cell
P
- Phase 1/2a
- An early clinical study that tests safety and dose in a small number of patients, and looks for first signs of activity. AGI-134 completed a Phase 1/2a study in 38 late-stage human patients.Related: AGI-134 · first-in-human
- preclinical
- The laboratory and animal research done before a candidate is given to people.Related: first-in-human · investigational
- pre-existing antibodies
- Antibodies a patient already has before treatment. Kode Immunoeducers are designed to recruit them, rather than relying solely on generating a new immune response.Related: complement
R
- rhamnose
- A sugar epitope presented by K5K, intended to recruit pre-existing antibodies.Related: K5K
S
- serologic mimic
- A kodecyte made to imitate the antigens of a blood group or other cell type, for antibody testing, quality assurance and teaching.Related: kodecyte
- spacer
- The part of an FSL construct that links the functional head to the lipid and presents it away from the surface.Related: FSL construct
Questions about Kode Technology: see the FAQ
Short answers to the questions people ask most about Kode Technology and Kode Immunoeducers.